Plaintiffs file a product liability lawsuit in Pensacola, Florida federal court against the manufacturers of Abilify, Bristol-Myers Squibb and Otsuka Pharmaceutical. Court documents allege the plaintiff suffered a gambling addiction from taking Abilify. About...
Abilify is an antipsychotic drug approved to treat symptoms of schizophrenia, irritability with autistic disorder, Tourette’s disorder, and episodes of mania or mixed episodes with bipolar disorder. Researchers now point to Abilify compulsive gambling as a side...
Abilify manufacturer, Bristol-Myers Squibb has reached a nearly $20 million settlement with a group of U.S. states. This comes after accusations that the company improperly marketed its medication. This is the second time the company has committed devious marketing...
Abilify compulsive behavior label in Canada and Europe warned patients that using the antipsychotic Abilify could cause a multitude of behaviors like excessive gambling, eating, and shopping. However, the manufacturer never warned American consumers. About...
MDL Judge M. Casey Rodgers has scheduled the first Abilify bellwether trial for June 18, 2018, in Pensacola, Florida. Abilify treats mental disorders such as schizophrenia and bipolar disorder. About 750 lawsuits claim the drug caused compulsive behavior, especially...
There is now a way for doctors to instantly know if you are taking your medication. Abilify MyCite is the first digital medicine to win U.S. Food and Drug Administration (FDA) approval. However, researchers fear digital ingestion could expose more to compulsive...
Recent Comments